Group One Trading
ALT icon

Group One Trading’s Altimmune ALT Stock Holding History

Group One Trading’s Portfolio ALT Stock Details ALT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$342K Sell
111,200
-312,500
-74% -$1.33M ﹤0.01% 3687
2025
Q4 		$1.53M Buy
423,700
+195,100
+85% +$851K ﹤0.01% 2504
2025
Q3 		$862K Sell
228,600
-423,700
-65% -$1.64M ﹤0.01% 3180
2025
Q2 		$2.52M Buy
652,300
+598,100
+1,104% +$3.24M 0.01% 1909
2025
Q1 		$271K Sell
54,200
-101,900
-65% -$645K ﹤0.01% 3711
2024
Q4 		$1.13M Buy
156,100
+59,800
+62% +$457K ﹤0.01% 2472
2024
Q3 		$591K Buy
96,300
+12,900
+15% +$87.4K ﹤0.01% 2735
2024
Q2 		$555K Buy
83,400
+13,400
+19% +$98.9K ﹤0.01% 2471
2024
Q1 		$713K Sell
70,000
-326,900
-82% -$3.32M ﹤0.01% 2405
2023
Q4 		$4.47M Buy
396,900
+340,300
+601% +$1.42M 0.01% 1228
2023
Q3 		$147K Buy
56,600
+21,000
+59% +$60.2K ﹤0.01% 4077
2023
Q2 		$126K Sell
35,600
-55,400
-61% -$249K ﹤0.01% 4391
2023
Q1 		$384K Buy
91,000
+52,500
+136% +$624K ﹤0.01% 3015
2022
Q4 		$633K Sell
38,500
-269,100
-87% -$3.02M ﹤0.01% 2820
2022
Q3 		$3.93M Buy
307,600
+277,000
+905% +$4.09M 0.01% 1357
2022
Q2 		$358K Buy
30,600
+1,800
+6% +$11.1K ﹤0.01% 3731
2022
Q1 		$175K Buy
28,800
+400
+1% +$2.95K ﹤0.01% 4937
2021
Q4 		$260K Sell
28,400
-14,700
-34% -$156K ﹤0.01% 4806
2021
Q3 		$487K Hold
43,100
– – ﹤0.01% 4211
2021
Q2 		$425K Buy
43,100
+4,900
+13% +$67K ﹤0.01% 4395
2021
Q1 		$540K Sell
38,200
-68,300
-64% -$1.1M ﹤0.01% 3951
2020
Q4 		$1.2M Buy
106,500
+73,600
+224% +$867K ﹤0.01% 2493
2020
Q3 		$434K Buy
32,900
+21,800
+196% +$436K ﹤0.01% 2969
2020
Q2 		$119K Buy
+11,100
New +$61K ﹤0.01% 3768
2018
Q4 		– Sell
-10,000
Closed -$44K – 4817
2018
Q3 		$44K Buy
+10,000
New +$109K ﹤0.01% 4035
2016
Q4 		– Sell
-146
Closed -$127K – 4390
2016
Q3 		$127K Buy
146
+66
+83% +$51.8K ﹤0.01% 2784
2016
Q2 		$59K Buy
+80
New +$54.7K ﹤0.01% 3203
2015
Q4 		– Sell
-11
Closed -$4K – 4699
2015
Q3 		$4K Hold
11
– – ﹤0.01% 4531
2015
Q2 		$6K Buy
11
+4
+57% +$2.02K ﹤0.01% 4431
2015
Q1 		$3K Sell
7
-46
-87% -$22.9K ﹤0.01% 4474
2014
Q4 		$29K Sell
53
-20
-27% -$10.3K ﹤0.01% 3744
2014
Q3 		$39K Sell
73
-10
-12% -$5.23K ﹤0.01% 3700
2014
Q2 		$35K Buy
83
+35
+73% +$15.8K ﹤0.01% 3779
2014
Q1 		$26K Buy
48
+47
+4,700% +$27.5K ﹤0.01% 4080
2013
Q4 		$1K Sell
1
-18
-95% -$10.7K ﹤0.01% 5122
2013
Q3 		$12K Sell
19
-147
-89% -$84.2K ﹤0.01% 4412
2013
Q2 		$79K Buy
+166
New +$82.3K ﹤0.01% 3030

Other funds holding ALT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Group One Trading's ALT Position: Q1 2026 in Review

Group One Trading reduced its Altimmune (ALT) stake by 79% in Q1 2026, selling an estimated $105K and leaving 6,695 shares worth $20.6K. The position accounts for ﹤0.01% of the portfolio, ranked #5951.

Group One Trading first reported a position in ALT in Q2 2013 and has held it in 38 quarters since. The position peaked at $6.16M in Q4 2023. 173 funds tracked by Wall St. Rank hold ALT as of Q1 2026.

  • Group One Trading held 6,695 shares of Altimmune worth $20.6K as of Q1 2026.
  • Group One Trading sold 24,677 Altimmune shares in Q1 2026, an estimated $105K.
  • Altimmune made up ﹤0.01% of Group One Trading's portfolio in Q1 2026, its #5951 holding.
  • Group One Trading first reported a position in Altimmune in Q2 2013 and has held it in 38 quarters since.
  • Group One Trading's Altimmune position peaked at $6.16M in Q4 2023.
  • 173 funds tracked by Wall St. Rank held Altimmune as of Q1 2026.

Based on Group One Trading's 13F filing for Q1 2026, filed 13 May 2026.